Literature DB >> 23355209

Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma.

Carlo Valentino1, Samantha Kendrick, Nathalie Johnson, Randy Gascoyne, Wing C Chan, Dennis Weisenburger, Rita Braziel, James R Cook, Raymond Tubbs, Elias Campo, Andreas Rosenwald, German Ott, Jan Delabie, Elaine Jaffe, Wenjun Zhang, Patrick Brunhoeber, Hiro Nitta, Tom Grogan, Lisa Rimsza.   

Abstract

Abnormalities of the MYC oncogene on chromosome 8 are characteristic of Burkitt lymphoma and other aggressive B-cell lymphomas, including diffuse large B-cell lymphoma (DLBCL). We recently described a colorimetric in situ hybridization (CISH) method for detecting extra copies of the MYC gene in DLBCL and the frequent occurrence of excess copies of discrete MYC signals in the context of diploidy or polyploidy of chromosome 8, which correlated with increased mRNA signals. We further observed enlarged MYC signals, which were counted as a single gene copy but, by their dimension and unusual shape, likely consisted of "clusters" of MYC genes. In this study, we sought to further characterize these clusters of MYC signals by determining whether the presence of these correlated with other genetic features, mRNA levels, protein, and overall survival. We found that MYC clusters correlated with an abnormal MYC locus and with increased mRNA. MYC mRNA correlated with protein levels, and both increased mRNA and protein correlated with poorer overall survival. MYC clusters were seen in both the germinal center and activated B-cell subtypes of DLBCL. Clusters of MYC signals may be an underappreciated, but clinically important, feature of aggressive B-cell lymphomas with potential prognostic and therapeutic relevance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23355209      PMCID: PMC3971877          DOI: 10.1309/AJCP2Z0TAGMUYJEB

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  21 in total

1.  Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma.

Authors:  Christopher J Stasik; Hiroaki Nitta; Wenjun Zhang; Charles H Mosher; James R Cook; Raymond R Tubbs; Joseph M Unger; Tracy A Brooks; Daniel O Persky; Sarah T Wilkinson; Thomas M Grogan; Lisa M Rimsza
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

Review 2.  MYC and aggressive B-cell lymphomas.

Authors:  Graham W Slack; Randy D Gascoyne
Journal:  Adv Anat Pathol       Date:  2011-05       Impact factor: 3.875

3.  Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.

Authors:  Lisa M Rimsza; Michael L Leblanc; Joseph M Unger; Thomas P Miller; Thomas M Grogan; Daniel O Persky; Ralph R Martel; Constantine M Sabalos; Bruce Seligmann; Rita M Braziel; Elias Campo; Andreas Rosenwald; Joseph M Connors; Laurie H Sehn; Nathalie Johnson; Randy D Gascoyne
Journal:  Blood       Date:  2008-06-10       Impact factor: 22.113

4.  MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.

Authors:  S O Yoon; Y K Jeon; J H Paik; W Y Kim; Y A Kim; J E Kim; C W Kim
Journal:  Histopathology       Date:  2008-08       Impact factor: 5.087

5.  Gene amplification in myeloid leukemias elucidated by fluorescence in situ hybridization.

Authors:  Kathleen C Rayeroux; Lynda J Campbell
Journal:  Cancer Genet Cytogenet       Date:  2009-08

6.  Automated brightfield break-apart in situ hybridization (ba-ISH) application: ALK and MALT1 genes as models.

Authors:  Hiroaki Nitta; Wenjun Zhang; Brian D Kelly; Melanie Miller; Lidija Pestic-Dragovich; Christopher Bieniarz; Thomas J Vasicek; Teresa Marafioti; Lisa Rimsza; Thomas M Grogan
Journal:  Methods       Date:  2010-07-16       Impact factor: 3.608

7.  Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression.

Authors:  Hyojin Kim; Seol-Bong Yoo; Ji-Young Choe; Jin Ho Paik; Xianhua Xu; Hiroaki Nitta; Wenjun Zhang; Thomas M Grogan; Choon-Taek Lee; Sanghoon Jheon; Jin-Haeng Chung
Journal:  J Thorac Oncol       Date:  2011-08       Impact factor: 15.609

8.  Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

Authors:  Nathalie A Johnson; Graham W Slack; Kerry J Savage; Joseph M Connors; Susana Ben-Neriah; Sanja Rogic; David W Scott; King L Tan; Christian Steidl; Laurie H Sehn; Wing C Chan; Javeed Iqbal; Paul N Meyer; Georg Lenz; George Wright; Lisa M Rimsza; Carlo Valentino; Patrick Brunhoeber; Thomas M Grogan; Rita M Braziel; James R Cook; Raymond R Tubbs; Dennis D Weisenburger; Elias Campo; Andreas Rosenwald; German Ott; Jan Delabie; Christina Holcroft; Elaine S Jaffe; Louis M Staudt; Randy D Gascoyne
Journal:  J Clin Oncol       Date:  2012-07-30       Impact factor: 44.544

9.  Stromal gene signatures in large-B-cell lymphomas.

Authors:  G Lenz; G Wright; S S Dave; W Xiao; J Powell; H Zhao; W Xu; B Tan; N Goldschmidt; J Iqbal; J Vose; M Bast; K Fu; D D Weisenburger; T C Greiner; J O Armitage; A Kyle; L May; R D Gascoyne; J M Connors; G Troen; H Holte; S Kvaloy; D Dierickx; G Verhoef; J Delabie; E B Smeland; P Jares; A Martinez; A Lopez-Guillermo; E Montserrat; E Campo; R M Braziel; T P Miller; L M Rimsza; J R Cook; B Pohlman; J Sweetenham; R R Tubbs; R I Fisher; E Hartmann; A Rosenwald; G Ott; H-K Muller-Hermelink; D Wrench; T A Lister; E S Jaffe; W H Wilson; W C Chan; L M Staudt
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245

10.  A strategy for full interrogation of prognostic gene expression patterns: exploring the biology of diffuse large B cell lymphoma.

Authors:  Lisa M Rimsza; Joseph M Unger; Margaret E Tome; Michael L Leblanc
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

View more
  11 in total

1.  The t(14;18)(q32;q21) with extra MYC signal - is it a gray zone lymphoma?

Authors:  Qin A Chang; Abdulraheem Qasem; Sheshadri Madhusudhana; Alexey Glazyrin
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma.

Authors:  Samantha L Kendrick; Lucas Redd; Andrea Muranyi; Leigh A Henricksen; Stacey Stanislaw; Lynette M Smith; Anamarija M Perry; Kai Fu; Dennis D Weisenburger; Andreas Rosenwald; German Ott; Randy D Gascoyne; Elaine S Jaffe; Elías Campo; Jan Delabie; Rita M Braziel; James R Cook; Raymond R Tubbs; Louis M Staudt; Wing Chung Chan; Christian Steidl; Thomas M Grogan; Lisa M Rimsza
Journal:  Hum Pathol       Date:  2014-06-26       Impact factor: 3.466

3.  MYC Analysis by Fluorescent In Situ Hybridization and Immunohistochemistry in Primary Adrenal Angiosarcoma (PAA): a Series of Four Cases.

Authors:  Kristine M Cornejo; Lloyd Hutchinson; Maryann St Cyr; Vania Nose; Patrick J McLaughlin; A John Iafrate; Peter M Sadow
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

4.  An increase in MYC copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimens.

Authors:  Francesca Schieppati; Piera Balzarini; Simona Fisogni; Alessandro Re; Chiara Pagani; Nicola Bianchetti; Lorenzo Micheli; Angela Passi; Samantha Ferrari; Adriana Maifredi; Chiara Bottelli; Rossella Leopaldo; Vilma Pellegrini; Fabio Facchetti; Giuseppe Rossi; Alessandra Tucci
Journal:  Haematologica       Date:  2019-08-08       Impact factor: 9.941

5.  Frequent expression of activation-induced cytidine deaminase in diffuse large B-cell lymphoma tissues from persons living with HIV.

Authors:  Volodymyr Shponka; Candace Y Reveles; Sinthia Alam; Melba Jaramillo; Alanna Maguire; Lisa M Rimsza; Samantha Kendrick
Journal:  AIDS       Date:  2020-11-15       Impact factor: 4.632

Review 6.  C-MYC aberrations as prognostic factors in diffuse large B-cell lymphoma: a meta-analysis of epidemiological studies.

Authors:  Kuangguo Zhou; Danmei Xu; Yang Cao; Jue Wang; Yunfan Yang; Mei Huang
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

7.  Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas.

Authors:  A N Seo; J M Yang; H Kim; S Jheon; K Kim; C T Lee; Y Jin; S Yun; J-H Chung; J H Paik
Journal:  Br J Cancer       Date:  2014-05-08       Impact factor: 7.640

8.  MYC expression in concert with BCL2 and BCL6 expression predicts outcome in Chinese patients with diffuse large B-cell lymphoma, not otherwise specified.

Authors:  Li-Xu Yan; Yan-Hui Liu; Dong-Lan Luo; Fen Zhang; Yu Cheng; Xin-Lan Luo; Jie Xu; Jie Cheng; Heng-Guo Zhuang
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

9.  MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma.

Authors:  Ting-Xun Lu; Lei Fan; Li Wang; Jia-Zhu Wu; Kou-Rong Miao; Jin-Hua Liang; Qi-Xing Gong; Zhen Wang; Ken H Young; Wei Xu; Zhi-Hong Zhang; Jian-Yong Li
Journal:  Oncotarget       Date:  2015-07-30

10.  Distribution of the c-MYC gene product in colorectal neoplasia.

Authors:  Ann-Marie Baker; Susan Van Noorden; Manuel Rodriguez-Justo; Patrizia Cohen; Nicholas A Wright; Irvin A Lampert
Journal:  Histopathology       Date:  2016-03-17       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.